Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults

BACKGROUND: Prophylactic vaccination with a quadrivalent HPV (types 6, 11, 16, 18) vaccine (qHPV) has been shown to prevent infection with HPV 6/11/16/18 and associated disease in women and more recently, in men. Here we report on the safety and reactogenicity of the qHPV vaccine in males. A total o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Moreira, Edson D, Palefsky, Joel M, Giuliano, Anna R, Goldstone, Stephen, Aranda, Carlos, Jessen, Heiko, Hillman, Richard J, Ferris, Daron, Coutlee, Francois, Vardas, Eftyhia, Marshall, J Brooke, Vuocolo, Scott, Haupt, Richard M, Guris, Dalya, Garner, Elizabeth IO
Formato: Artigo
Lenguaje:Inglês
Publicado: Landes Bioscience 2011
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3219080/
https://ncbi.nlm.nih.gov/pubmed/21712645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.7.7.15579
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares